{"pmid":32311322,"title":"Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.","text":["Chloroquine or hydroxychloroquine for prophylaxis of COVID-19.","Lancet Infect Dis","Principi, Nicola","Esposito, Susanna","32311322"],"journal":"Lancet Infect Dis","authors":["Principi, Nicola","Esposito, Susanna"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311322","week":"202017|Apr 20 - Apr 26","doi":"10.1016/S1473-3099(20)30296-6","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664632501387132928,"score":8.518259,"similar":[{"pmid":32311324,"title":"Hydroxychloroquine prophylaxis for COVID-19 contacts in India.","text":["Hydroxychloroquine prophylaxis for COVID-19 contacts in India.","Lancet Infect Dis","Rathi, Sahaj","Ish, Pranav","Kalantri, Ashwini","Kalantri, Shriprakash","32311324"],"journal":"Lancet Infect Dis","authors":["Rathi, Sahaj","Ish, Pranav","Kalantri, Ashwini","Kalantri, Shriprakash"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32311324","week":"202017|Apr 20 - Apr 26","doi":"10.1016/S1473-3099(20)30313-3","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["India"],"countries":["India"],"countries_codes":["IND|India"],"_version_":1664632501394472960,"score":82.23803},{"pmid":32269046,"title":"Chloroquine and hydroxychloroquine in covid-19.","text":["Chloroquine and hydroxychloroquine in covid-19.","BMJ","Ferner, Robin E","Aronson, Jeffrey K","32269046"],"journal":"BMJ","authors":["Ferner, Robin E","Aronson, Jeffrey K"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269046","week":"202015|Apr 06 - Apr 12","doi":"10.1136/bmj.m1432","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine","Hydroxychloroquine"],"_version_":1664637315588292609,"score":68.804276},{"pmid":32247518,"title":"COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?","text":["COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?","Am J Ophthalmol","Marmor, Michael F","32247518"],"journal":"Am J Ophthalmol","authors":["Marmor, Michael F"],"date":"2020-04-06T11:00:00Z","year":2020,"_id":"32247518","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ajo.2020.03.028","source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Chloroquine","Hydroxychloroquine"],"_version_":1664637850759462912,"score":62.14457},{"pmid":32231348,"title":"Emerging prophylaxis strategies against COVID-19.","text":["Emerging prophylaxis strategies against COVID-19.","The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus.","Monaldi Arch Chest Dis","Agrawal, Sumita","Goel, Akhil Dhanesh","Gupta, Nitesh","32231348"],"abstract":["The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus."],"journal":"Monaldi Arch Chest Dis","authors":["Agrawal, Sumita","Goel, Akhil Dhanesh","Gupta, Nitesh"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32231348","week":"202014|Mar 30 - Apr 05","doi":"10.4081/monaldi.2020.1289","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638455233118208,"score":60.659363},{"pmid":32278018,"pmcid":"PMC7141642","title":"Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.","text":["Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.","Indian Pacing Electrophysiol J","Kapoor, Aditya","Pandurangi, Ulhas","Arora, Vanita","Gupta, Anoop","Jaswal, Aparna","Nabar, Ashish","Naik, Ajay","Naik, Nitish","Namboodiri, Narayanan","Vora, Amit","Yadav, Rakesh","Saxena, Anil","32278018"],"journal":"Indian Pacing Electrophysiol J","authors":["Kapoor, Aditya","Pandurangi, Ulhas","Arora, Vanita","Gupta, Anoop","Jaswal, Aparna","Nabar, Ashish","Naik, Ajay","Naik, Nitish","Namboodiri, Narayanan","Vora, Amit","Yadav, Rakesh","Saxena, Anil"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32278018","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ipej.2020.04.003","keywords":["covid-19","heart disease","hydroxychloroquine","qtc interval","torsade de pointes"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Hydroxychloroquine"],"_version_":1664636943990784000,"score":59.773445}]}